atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial of RL-007 in Cognitive Impairment Associated… Dec 14, 2021
Study Shows Promise In Cure For Alzheimers: MYND Life Sciences Looks To Biomarkets In Fight Against Mental Disease Nov 23, 2021